Item
“The Simple Rule That Could Keep COVID-19 Deaths Down” - The Atlantic Monthly
Title (Dublin Core)
“The Simple Rule That Could Keep COVID-19 Deaths Down” - The Atlantic Monthly
Description (Dublin Core)
Aside from “flattening the curve” of infections, the longer one avoids contracting COVID-19 also ensures that one will have a higher survival rate. This observation was made by Sarah Zhang, a journalist writing for the Atlantic Monthly who has published several articles concerning the pandemic. In this particular article, Zhang briefly summarizes the reasons why it is better for one to get infected later than sooner, supporting each point with peer-reviewed research and statistical data.
According to Zhang, one of the most important reasons why it is better to get infected later than earlier is that medical treatments of COVID-19 have been gradually improving since the pandemic began. For instance, ventilators were initially prescribed for most COVID-19 patients, but they were eventually reserved for extreme cases. Other, less invasive oxygen therapies have been prescribed for milder cases. Similarly, new drugs such as Dexamethasone have been prescribed to more patients as medical knowledge about COVID-19 gradually increased. These innovations are reflected in the slightly reduced death toll.
However, Zhang reminds readers that despite these improvements in medical treatments, COVID-19 still has several confounding aspects. Furthermore, several experimental treatments and vaccines are still in testing phases, and will not be viable until well into 2021.
According to Zhang, one of the most important reasons why it is better to get infected later than earlier is that medical treatments of COVID-19 have been gradually improving since the pandemic began. For instance, ventilators were initially prescribed for most COVID-19 patients, but they were eventually reserved for extreme cases. Other, less invasive oxygen therapies have been prescribed for milder cases. Similarly, new drugs such as Dexamethasone have been prescribed to more patients as medical knowledge about COVID-19 gradually increased. These innovations are reflected in the slightly reduced death toll.
However, Zhang reminds readers that despite these improvements in medical treatments, COVID-19 still has several confounding aspects. Furthermore, several experimental treatments and vaccines are still in testing phases, and will not be viable until well into 2021.
Date (Dublin Core)
Creator (Dublin Core)
Contributor (Dublin Core)
Type (Dublin Core)
link
Link (Bibliographic Ontology)
Controlled Vocabulary (Dublin Core)
Curator's Tags (Omeka Classic)
Contributor's Tags (a true folksonomy) (Friend of a Friend)
Collection (Dublin Core)
Date Submitted (Dublin Core)
11/05/2020
Date Modified (Dublin Core)
11/06/2020
1/31/2021
Date Created (Dublin Core)
10/30/2020
Item sets
This item was submitted on November 5, 2020 by Carlos Castro using the form “Share Your Story” on the site “A Journal of the Plague Year”: http://www.covid-19archive.org/s/archive
Click here to view the collected data.